# Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.

> **NCT00232882** · PHASE4 · COMPLETED · sponsor: **Institut de Recherches Cliniques de Montreal** · enrollment: 86 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Candesartan Thiazide
- **DRUG:** Atenolol Thiazide
- **DRUG:** Thiazide Candesartan

## Key facts

- **NCT ID:** NCT00232882
- **Lead sponsor:** Institut de Recherches Cliniques de Montreal
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2013-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232882, "Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00232882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*